Literature DB >> 11081871

Morbidity and mortality after 94 extrapleural pneumonectomies for empyema.

Y Shiraishi1, Y Nakajima, A Koyama, K Takasuna, N Katsuragi, S Yoshida.   

Abstract

BACKGROUND: Extrapleural pneumonectomy is still indicated in some patients with empyema. We examined morbidity and mortality after this high-risk operation.
METHODS: Between 1979 and 1998, 94 (92 chronic, 2 postsurgical) patients with empyema underwent extrapleural pneumonectomy. There were 79 men and 15 women (mean age, 59 years). Eighty-eight patients had a history of tuberculosis, and 53 had undergone a therapeutic pneumothorax. The right side was operated on in 50 patients and left in 44.
RESULTS: Operative mortality was 8.5%. Fifteen major complications (1 esophageal perforation, 9 empyemas, and 5 bronchopleural fistulas) occurred in 13 patients. Eight patients required reexploration for hemorrhage. Reexploration was a risk factor for empyema. Bronchopleural fistulas occurred only on the right side. Eighty-nine percent of the 86 operative survivors were free of empyemas at 5 years. Overall 5-year survival was 83%, and survival was better in patients without than in those with empyema.
CONCLUSIONS: Extrapleural pneumonectomy for empyema has acceptable morbidity and mortality. Postoperative empyema affects prognosis. Covering a bronchial stump with muscle is recommended, especially when the operation is performed on the right side.

Entities:  

Mesh:

Year:  2000        PMID: 11081871     DOI: 10.1016/s0003-4975(00)01612-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Analysis of Pneumonectomy for Benign Disease: A Single Institution Retrospective Study on 59 Patients.

Authors:  Lei Yang; Chun-Liu Ding; Xiu-Jun Chang; Fu-Gen Li; Tian-Hui Zhang; Zi-Tong Wang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-05-25       Impact factor: 1.520

2.  Acute empyema with intractable pneumothorax associated with ruptured lung abscess caused by Mycobacterium avium.

Authors:  Katsuyuki Asai; Norikazu Urabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

Review 3.  Surgical treatment of chronic empyema.

Authors:  Yuji Shiraishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-07-14

Review 4.  Surgery and pleuro-pulmonary tuberculosis: a scientific literature review.

Authors:  Dragan Subotic; Piotr Yablonskiy; Giorgia Sulis; Ioan Cordos; Danail Petrov; Rosella Centis; Lia D'Ambrosio; Giovanni Sotgiu; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

5.  Completion pneumonectomy after fenestration for empyema due to nontuberculous mycobacteriosis associated with destroyed lung as a result of cancer surgery.

Authors:  Ryo Takahashi; Taiki Fujiwara; Hisami Yamakawa
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

6.  Surgical treatment for chronic lung and thoracic cavity infection.

Authors:  Masanori Kaneda; Tomohito Tarukawa; Fumiaki Watanabe; Katsutoshi Adachi; Takashi Sakai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-02-12

7.  Early and Long-term Outcomes of Pneumonectomy for Treating Sequelae of Pulmonary Tuberculosis.

Authors:  Chun Sung Byun; Kyung Young Chung; Kyoung Sik Narm; Jin Gu Lee; Daejin Hong; Chang Young Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-04-03

8.  Salmonella houtenae-induced Empyema Complicated with Chronic Tuberculous Empyema.

Authors:  Yuichi Mukai; Toshihiko Agatsuma; Gen Ideura
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

9.  Factors affecting complication rates of pneumonectomy in destroyed lung.

Authors:  Aysun Kosif Mısırlıoğlu; Serkan Bayram; Hakan Kıral; Meltem Çoban Ağca; Fatma Tokgöz Akyıl; Levent Alpay; Volkan Baysungur; İrfan Yalçınkaya
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

10.  Cavernostomy for Pulmonary Aspergillosis Associated with Destroyed Lung after Surgery for Lung Cancer: Report of 3 Cases.

Authors:  Ryo Takahashi; Taiki Fujiwara; Hisami Yamakawa
Journal:  Case Rep Surg       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.